| Molecular formula | C35H59N11O10 |
| Molecular weight | 793.9 g/mol |
| Registered trials | 0 |
| PubChem CID | 133082488 |
What N-Acetyl Selank Is
N-Acetyl Selank is a synthetic peptide compound identified in chemical databases under PubChem CID 133082488. It has a molecular formula of C35H59N11O10 and a molecular weight of approximately 793.9 g/mol. There is no FDA-approved drug label for this compound, and it has not been evaluated by regulatory agencies for safety or effectiveness in humans. N-Acetyl Selank is classified as an unapproved research compound, meaning any use outside of a controlled laboratory or research setting falls outside established regulatory oversight.
Trial Footprint
Based on available registry data, there are no registered clinical trials for N-Acetyl Selank. This absence of trial data means there is no clinical evidence available from human studies to describe regarding safety, tolerability, or any other outcome measure for this compound.
FAQ
No. N-Acetyl Selank has no FDA-approved label and is classified as an unapproved research compound. It has not been evaluated by regulatory agencies for safety or effectiveness in humans.
Current registry data shows no registered clinical trials for N-Acetyl Selank. This means there is no published human trial data available to describe its effects or safety profile.
N-Acetyl Selank is cataloged in PubChem under CID 133082488, with a molecular formula of C35H59N11O10 and a molecular weight of about 793.9 g/mol. This chemical identity information comes from public chemical databases rather than a regulatory label.
No side effect or adverse event report data is currently available for N-Acetyl Selank. Without an approved label or clinical trial history, there is no dataset to summarize regarding reported reactions.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-09-19